The Baker Institute is proud to partner with the Boehringer Ingelheim and Eli Lilly Australia & New Zealand Diabetes Alliance with the aim of bringing people together to focus on creating a healthier Australia.
Our shared values and desire is to make a difference to patients living with diabetes and heart disease. Our partnership and engagement aims to improve the knowledge of healthcare professionals, through a broad range of activities, such as the Dark shadow of type 2 diabetes report and GP Symposia, with impacts reaching nationally and globally.